Telix Pharmaceuticals announced that it agreed to acquire radioisotope production technology firm ARTMS Inc. ARTMS also brings with it an advanced cyclotron-based isotope production platform and manufacturing plant. It has a stockpile of ultra-pure rare metals required for consumable target production, too, according to a news release. The company specializes in the physics, chemistry and…